Cathay Biotech Inc. (SHA:688065)
China
· Delayed Price · Currency is CNY 46.01
+0.58 (1.28%)
At close: Dec 5, 2025
Cathay Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Operating Revenue | 3,149 | 2,819 | 2,067 | 2,332 | 2,296 | 1,488 | Upgrade
|
| Other Revenue | 138.84 | 138.84 | 47.17 | 108.67 | 67.67 | 9.49 | Upgrade
|
| Revenue | 3,288 | 2,958 | 2,114 | 2,441 | 2,363 | 1,497 | Upgrade
|
| Revenue Growth (YoY) | 18.96% | 39.91% | -13.39% | 3.28% | 57.86% | -21.87% | Upgrade
|
| Cost of Revenue | 2,280 | 2,121 | 1,535 | 1,612 | 1,526 | 808.77 | Upgrade
|
| Gross Profit | 1,008 | 836.44 | 579.23 | 829.2 | 837.21 | 688.42 | Upgrade
|
| Selling, General & Admin | 229.38 | 222 | 221.61 | 232.28 | 175.11 | 143.25 | Upgrade
|
| Research & Development | 243.11 | 233.34 | 189.13 | 187.71 | 133.53 | 84.3 | Upgrade
|
| Other Operating Expenses | 15.05 | 13.83 | 9.21 | -4.09 | 22.94 | 10.45 | Upgrade
|
| Operating Expenses | 500.29 | 472.51 | 413.68 | 422.59 | 337.95 | 241.23 | Upgrade
|
| Operating Income | 507.43 | 363.93 | 165.55 | 406.61 | 499.25 | 447.19 | Upgrade
|
| Interest Expense | -13.95 | -27.43 | -32.17 | -20.01 | -16.29 | -3.86 | Upgrade
|
| Interest & Investment Income | 185.57 | 160.75 | 219.77 | 236.78 | 229.61 | 52.18 | Upgrade
|
| Earnings From Equity Investments | -8.95 | -8.95 | -7.82 | -3.71 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 36.73 | 36.73 | 29.59 | 82.97 | -14.14 | -18.26 | Upgrade
|
| Other Non Operating Income (Expenses) | -7.23 | -6.04 | -5.7 | -4.61 | -0.59 | -0.32 | Upgrade
|
| EBT Excluding Unusual Items | 699.61 | 518.99 | 369.22 | 698.03 | 697.84 | 476.93 | Upgrade
|
| Gain (Loss) on Sale of Investments | 6.45 | - | - | - | - | 9.15 | Upgrade
|
| Gain (Loss) on Sale of Assets | 7.13 | 0.42 | -0.01 | 0.07 | - | - | Upgrade
|
| Asset Writedown | -74.27 | -0.05 | -0.26 | -0.02 | -0.06 | -1.15 | Upgrade
|
| Other Unusual Items | 25.14 | 28.66 | 79.97 | -2.09 | 26.66 | 35.85 | Upgrade
|
| Pretax Income | 664.06 | 548.02 | 448.92 | 695.99 | 724.45 | 520.79 | Upgrade
|
| Income Tax Expense | 105 | 73.43 | 40.39 | 83.34 | 90.94 | 63.45 | Upgrade
|
| Earnings From Continuing Operations | 559.06 | 474.59 | 408.54 | 612.65 | 633.51 | 457.34 | Upgrade
|
| Minority Interest in Earnings | 35.4 | 14.37 | -42.01 | -59.39 | -38.79 | 0.33 | Upgrade
|
| Net Income | 594.46 | 488.96 | 366.52 | 553.27 | 594.72 | 457.67 | Upgrade
|
| Net Income to Common | 594.46 | 488.96 | 366.52 | 553.27 | 594.72 | 457.67 | Upgrade
|
| Net Income Growth | 49.43% | 33.41% | -33.75% | -6.97% | 29.94% | -4.43% | Upgrade
|
| Shares Outstanding (Basic) | 648 | 582 | 582 | 582 | 583 | 543 | Upgrade
|
| Shares Outstanding (Diluted) | 648 | 582 | 582 | 582 | 583 | 543 | Upgrade
|
| Shares Change (YoY) | 10.81% | 0.05% | -0.10% | -0.11% | 7.38% | 6.91% | Upgrade
|
| EPS (Basic) | 0.92 | 0.84 | 0.63 | 0.95 | 1.02 | 0.84 | Upgrade
|
| EPS (Diluted) | 0.92 | 0.84 | 0.63 | 0.95 | 1.02 | 0.84 | Upgrade
|
| EPS Growth | 34.86% | 33.33% | -33.68% | -6.86% | 21.01% | -10.61% | Upgrade
|
| Free Cash Flow | -327.46 | -22.38 | -1,000 | -3,395 | -880.49 | -248.15 | Upgrade
|
| Free Cash Flow Per Share | -0.51 | -0.04 | -1.72 | -5.83 | -1.51 | -0.46 | Upgrade
|
| Dividend Per Share | 0.400 | 0.400 | 0.190 | 0.180 | 0.321 | 0.571 | Upgrade
|
| Dividend Growth | 110.53% | 110.53% | 5.56% | -43.99% | -43.75% | - | Upgrade
|
| Gross Margin | 30.65% | 28.28% | 27.40% | 33.97% | 35.42% | 45.98% | Upgrade
|
| Operating Margin | 15.43% | 12.30% | 7.83% | 16.66% | 21.12% | 29.87% | Upgrade
|
| Profit Margin | 18.08% | 16.53% | 17.34% | 22.66% | 25.16% | 30.57% | Upgrade
|
| Free Cash Flow Margin | -9.96% | -0.76% | -47.32% | -139.06% | -37.25% | -16.57% | Upgrade
|
| EBITDA | 846.01 | 679.85 | 451.26 | 671.73 | 667.79 | 565.51 | Upgrade
|
| EBITDA Margin | 25.73% | 22.98% | 21.34% | 27.52% | 28.25% | 37.77% | Upgrade
|
| D&A For EBITDA | 338.57 | 315.92 | 285.72 | 265.12 | 168.54 | 118.32 | Upgrade
|
| EBIT | 507.43 | 363.93 | 165.55 | 406.61 | 499.25 | 447.19 | Upgrade
|
| EBIT Margin | 15.43% | 12.30% | 7.83% | 16.66% | 21.12% | 29.87% | Upgrade
|
| Effective Tax Rate | 15.81% | 13.40% | 9.00% | 11.97% | 12.55% | 12.18% | Upgrade
|
| Revenue as Reported | 3,288 | 2,958 | 2,114 | 2,441 | 2,363 | 1,497 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.